SMG European Recovery SPAC SE (FRA:RCVR) insiders have significant skin in the game with 62% ownership

Every investor in SMG European Recovery SPAC SE (FRA:RCVR) should be aware of the most powerful shareholder groups. The group holding the most number of shares in the company, around 62% to be precise, is individual insiders. That is, the group stands to benefit the most if the stock rises (or lose the most if there is a downturn).

So, insiders of SMG European Recovery SPAC have a lot at stake and every decision they make on the company’s future is important to them from a financial point of view.

Let's take a closer look to see what the different types of shareholders can tell us about SMG European Recovery SPAC.

Check out our latest analysis for SMG European Recovery SPAC

ownership-breakdown
DB:RCVR Ownership Breakdown November 2nd 2022

What Does The Institutional Ownership Tell Us About SMG European Recovery SPAC?

Institutions typically measure themselves against a benchmark when reporting to their own investors, so they often become more enthusiastic about a stock once it's included in a major index. We would expect most companies to have some institutions on the register, especially if they are growing.

Since institutions own only a small portion of SMG European Recovery SPAC, many may not have spent much time considering the stock. But it's clear that some have; and they liked it enough to buy in. If the company is growing earnings, that may indicate that it is just beginning to catch the attention of these deep-pocketed investors. When multiple institutional investors want to buy shares, we often see a rising share price. The past revenue trajectory (shown below) can be an indication of future growth, but there are no guarantees.

earnings-and-revenue-growth
DB:RCVR Earnings and Revenue Growth November 2nd 2022

It looks like hedge funds own 5.0% of SMG European Recovery SPAC shares. That catches my attention because hedge funds sometimes try to influence management, or bring about changes that will create near term value for shareholders. The company's CEO Stefan Petrikovics is the largest shareholder with 37% of shares outstanding. Alain de Krassny is the second largest shareholder owning 21% of common stock, and Obotritia Capital KGaA holds about 12% of the company stock.

After doing some more digging, we found that the top 2 shareholders collectively control more than half of the company's shares, implying that they have considerable power to influence the company's decisions.

While studying institutional ownership for a company can add value to your research, it is also a good practice to research analyst recommendations to get a deeper understand of a stock's expected performance. Our information suggests that there isn't any analyst coverage of the stock, so it is probably little known.